Levy Richard S
SEC Form 4 insider trading activity
Levy Richard S has filed 8 SEC Form 4 filings (34 transaction rows) across 2 companies, including KNSA, MDGL, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Aug 4, 2026.
On the most recent filing, Levy Richard S is listed as Director at MADRIGAL PHARMACEUTICALS, INC. Inside the rolling window, Levy Richard S reported no open-market purchases and 2 open-market sales totaling $7.4M in MDGL. The largest disclosed transaction in the window is a sale of 8,500 MDGL shares on Nov 13, 2025, worth $4.4M.
Companies traded
Other insiders at KNSA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.4M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Levy Richard S made?
Levy Richard S has filed 8 SEC Form 4 filings (34 transaction rows) across 2 companies, including KNSA, MDGL since 2025.
Which companies does Levy Richard S trade?
Levy Richard S has filed SEC Form 4 disclosures for 2 companies, including KNSA, MDGL.
When was Levy Richard S's most recent SEC Form 4 filing?
Levy Richard S's most recent SEC Form 4 filing on Tracefour is dated Aug 4, 2026.
What is Levy Richard S's total buy and sell value in the current window?
Inside the rolling retention window, Levy Richard S bought $0 and sold $7.4M based on SEC Form 4 filings.
What was Levy Richard S's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 8,500 MDGL shares on 2025-11-13, worth $4.4M, per SEC Form 4 filings.